Clinical Evidence & Decision Support · Assurance Record
UpToDate Expert AI
Wolters Kluwer (UpToDate) · Hospital and ambulatory point-of-care, mobile, enterprise clinical intelligence platform · Enterprise SaaS: mobile app + CDS platform, integrated into EHRs (Epic) and ambient AI tools (Microsoft Dragon, Abridge)
Decision summary
- Suitable for
- Hospitals and health systems (UpToDate Enterprise Edition); clinicians at the point of care
- Documentary gate
- Failed
- Scenario match
- No evaluated buying scenario currently covers this product
- Comparability
- Not yet comparable in this scenario
- Decision readiness
- HISTORICAL — Research only
- Documented evidence
- 0 of 4 evidence claims independently confirmed · confidence Low
- Critical unknowns
- scaled production deployment · security and governance evidence · documented economic outcomes · organizational and market durability
- Last independent review
- not yet measured
press releaseApproximately 2,500 U.S. hospitals and health systems - over 90% of U.S. UpToDate Enterprise Edition customers - have adopted UpToDate Exper…2026-08-06
Exact claim. Approximately 2,500 U.S. hospitals and health systems - over 90% of U.S. UpToDate Enterprise Edition customers - have adopted UpToDate Expert AI, including Sharp HealthCare, Duke University Health System, University of Iowa Health Care, and Intermountain Health (34 sites)
- Source
- markets.ft.com
- Type
- press release
- Published
- 2026-08-06
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- deployment_traction
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open markets.ft.compress releaseWolters Kluwer launched UpToDate Expert AI, a generative AI CDS solution grounded solely in UpToDate evidence-based content with transparent…2025-09-30
Exact claim. Wolters Kluwer launched UpToDate Expert AI, a generative AI CDS solution grounded solely in UpToDate evidence-based content with transparent assumptions and rationale, available to select UpToDate Enterprise Edition customers beginning Q4 2025
- Source
- wolterskluwer.com
- Type
- press release
- Published
- 2025-09-30
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- general
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open wolterskluwer.compress releaseSince launching in September 2025, Wolters Kluwer has been working with more than 50 major U.S. health systems to deploy UpToDate Expert AI …2025-12-31
Exact claim. Since launching in September 2025, Wolters Kluwer has been working with more than 50 major U.S. health systems to deploy UpToDate Expert AI enterprise-wide, and added comprehensive medication information from UpToDate Lexidrug (~3,000 drug topics) to the AI
- Source
- wolterskluwer.com
- Type
- press release
- Published
- 2025-12-31
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- deployment_traction
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open wolterskluwer.compress releaseWolters Kluwer launched UpToDate Expert AI (GenAI clinical decision support), initially available to Enterprise Edition customers from Q4 20…2026-08-15
Exact claim. Wolters Kluwer launched UpToDate Expert AI (GenAI clinical decision support), initially available to Enterprise Edition customers from Q4 2025.
- Source
- wolterskluwer.com
- Type
- press release
- Published
- 2026-08-15
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- interoperability
- Score contribution
- Feeds interoperability
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open wolterskluwer.comVerified provider experience is not yet publishable. Fewer than five independent provider organizations have contributed eligible reviews. Reviewer mode is off. Experience never changes documentary scoring, freshness, or rank.
Buyer lenses — evidence-backed bands (not a 0–100 rank)
Deployment, integration, data handling
- Integration maturity
- announced — Announced or documented integration; marketplace listing not confirmed.
- EHR path
- Epic
- FHIR / API
- UNKNOWN
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.
- SSO
- UNKNOWN
Why unknown
Why. Single-sign-on support is not documented in vendor or marketplace materials on file.
What would close it. Vendor security documentation or marketplace listing mentioning SSO/SAML/OIDC.
- PHI / BAA
- No patient data required for use; patient education content integrated into Epic MyChart workflows under enterprise agreements; enterprise governance and analytics features
- Security attestations
- UNKNOWN
- FDA status
- UNKNOWN
Why unknown
Why. No FDA listing found for this product's functions in the tracked category.
What would close it. An FDA 510(k)/De Novo listing, or a clear statement that no regulated function is claimed.
- Pricing
- Not publicly listed
Technical provenance
snap_8a8a4c9bb810aee3 · 2026-08-27T04:05Z · build 6a9fe1b
Forecast calibration is not in the public snapshot — shown as UNKNOWN rather than read from SQLite.
Known limitations
- Deployment traction is UNKNOWN.
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.
- Trust & governance is UNKNOWN.
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.
- Economic value evidence is UNKNOWN.
Why unknown
Why. No independently verifiable ROI claim (peer-reviewed, audited case, or independent benchmark) is on file.
What would close it. An audited implementation report or peer-reviewed study with payback/throughput numbers.
- Market durability is UNKNOWN.
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.